AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

Remifentanil Hydrochloride Equivalent To Remifentanil

13 registrations across 1 African market— 10 active

Markets with Remifentanil Hydrochloride Equivalent To Remifentanil

Recent registrations

Brand / ProductMarketHolderStatusExpires
REMIFENTANIL 1 mg ADCO🇿🇦South AfricaAdcock Ingram Critical Care (Pty) LtdactiveJun 2030
REMIFENTANIL 2 mg ADCOC🇿🇦South AfricaAdcock Ingram Critical Care (Pty) LtdactiveJun 2030
REMIFENTANIL 5 mg ADCO🇿🇦South AfricaAdcock Ingram Critical Care (Pty) LtdactiveJun 2030
REMIFENTANIL 5 ASPEN🇿🇦South AfricaAspen SA Operations (Pty) LtdactiveOct 2028
REMIFENTANIL TEVA 5🇿🇦South AfricaTeva Pharmaceuticals (Pty) LtdsuspendedAug 2023
REMIFENTANIL TEVA 1🇿🇦South AfricaTeva Pharmaceuticals (Pty) LtdsuspendedAug 2023
REMIFENTANIL TEVA 2🇿🇦South AfricaTeva Pharmaceuticals (Pty) LtdsuspendedAug 2023
ULTIVA 5 mg (INJECTION)🇿🇦South AfricaPharmacare Limited û WoodmeadactiveJan 1900
FORTIVA 1 mg🇿🇦South AfricaPharmacare Limited û WoodmeadactiveJan 1900
ULTIVA 2 mg🇿🇦South AfricaPharmacare Limited û WoodmeadactiveJan 1900
FORTIVA 2 mg🇿🇦South AfricaPharmacare Limited û WoodmeadactiveJan 1900
FORTIVA 5 mg🇿🇦South AfricaPharmacare Limited û WoodmeadactiveJan 1900
ULTIVA 1 mg🇿🇦South AfricaPharmacare Limited û WoodmeadactiveJan 1900

Remifentanil Hydrochloride Equivalent To Remifentanil in Africa — Regulatory Overview

Remifentanil Hydrochloride Equivalent To Remifentanil is registered across 1 African markets with 13 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa. AfricaRegulatory refreshes this data daily from official government sources.

Of the 13 registrations, 10 (77%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.